P. Reková

Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic

A. Linhart, A. Tomek, M. Vaněčková, 2021, Journal of clinical medicine.

AGAL misprocessing-induced ER stress and the unfolded protein response: lysosomal storage-independent mechanism of Fabry disease pathogenesis?

K. Hodaňová, H. Hartmannová, S. Kmoch, 2022, bioRxiv.

Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events

Murali K. Kolikonda, C. Nolte, M. Reiser, 2022, Neurology.

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

D. Tanné, D. Blacker, S. Connolly, 2018, The Lancet. Neurology.

Fabry disease, an overview and the most common neurological manifestations

A. Linhart, G. Dostálová, P. Reková, 2018 .

Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?

A. Linhart, B. Srpova, T. Uher, 2023, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

Prevalence of Dichelobacter nodosus and Fusobacterium necrophorum on dairy farms in Slovakia

D. Döpfer, C. Tóthová, P. Mudroň, 2023, Journal of Applied Animal Research.

Cerebrovascular Phenotype in Fabry Disease Patients Assessed by Ultrasound

M. Pavlicova, A. Linhart, M. Vaněčková, 2023, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events

Murali K. Kolikonda, C. Nolte, M. Reiser, 2023, Neurology.

Anderson–Fabry Disease Homozygosity: Rare Case of Late-Onset Variant

D. Zemánek, G. Dostálová, P. Reková, 2024, Cardiogenetics.